On May 27, the medical website recently, I went to buy cough medicine 2 Chen pills. This medicine consists of Chen PI, half summer, poria and licorice, the price is only 20 yuan. As a result, the local drugstore was not available for years. 

 

Not only two Chen pills, but in recent years cheap drugs have been "missing" frequently. 1 yuan 1 of chloramphenicol eye drops, and 2 RMB 100 of new Ming, 3 yuan 1 box of bezoar poison pill, a few yuan a box of norfloxacin, 8 yuan 100 pieces of periodontal spirit and so on, almost disappeared in the market. The drug price is lower, but the curative effect, "better not expensive", is widely recognized in the people, the market demand is huge, so their shortage is a major concern. 

 

When people have demand, why don't they produce it? In a recent list released by the guangdong pharmaceutical trading center, there were as many as 1,004 drug breaks, leading to the availability of drugs. In the case of drugs, companies don't want to supply, they can't produce, because the cost of production is so much different from that of the winning bid. Glucose injection, for example, the cost price of 1.8 yuan, price of 1.2 yuan, this means that as long as to produce loss, enterprises do not supply, only on the "blacklist". The hard work is a hot potato. 

 

Medicine is a special commodity, and patients have rigid requirements. To prevent cheap drugs from disappearing, the government has to do so. Last year, the national development and reform commission released a list of low-priced medicines that allowed low-price drugs to rise at reasonable prices, and some lower-priced medicines returned to the market. This year, Beijing introduced a comprehensive reform of medicine, with a price of more than 30 yuan and a quick fix of more than 30 yuan. Even though a box of more than nine yuan has increased the supply of the market, people no longer worry about buying life-saving drugs. Although government intervention is effective, it cannot rely too much on the "visible hand". To fundamentally solve the problem, you must use the "invisible hand". 

 

The shortage of medicines is largely due to irrational pricing, and a corporate shutdown is an instinctive response. As long as drugs cost more than the market price, cheap drugs will be hard to find. According to market economy law, once raw material price rises, drug price should float. For example, in the process of the provincial drug purchase, the average price of the bid price reference, into the market, and negotiation is often in the past 4-5 years of data, but the production cost especially the cost of raw materials is rising year by year. Take vitamin B1, for example, the previous one kilogram was 230 yuan, now over 1800 yuan, sometimes even 2,000 yuan. In addition to the policies such as the new GMP standard certification and the consistency evaluation, the upgrade of the enterprise to the workshop and the product, also promoted the cost of medicine. However, it is often difficult for government departments to master the exact timing of price changes. That is to say, the drugs once bid into the medicare payment system at a low price and within a few years, even if costs rise cannot adjust the price according to the market situation, can only be cut off. The result is a shortage of drugs, and the black market price is soaring. For example, the price of penicillide, a treatment for liver disease, is less than 10 yuan and is sold for nearly 100 yuan. Centralized purchasing purpose is to let people get to use inexpensive drugs, but if ignored the economic law, willing to manage prices, low medicine would not disappear. 

 

The market is changing rapidly and the price cannot be "fixed", but it must be "moved". Only in the market place, drug dynamic pricing can be applied to the market. Monitoring system at the same time, establish strict cost, enhance public pricing process, it can prevent pharmaceutical companies inflate costs, and can guarantee the reasonable cost of cheap drugs. Medical institutions can consult the prices of neighboring provinces and negotiate the price of supply with the production enterprises. 

 

The establishment of a scientific drug pricing mechanism is a major issue of healthcare reform. Government departments should be farewell "JiuHuoShi" thinking, better play the decisive role of market mechanism, and ensure the people demand, to cheap medicine is no longer a "legend".